Immutep (IMMP) Cash from Financing Activities (2016 - 2017)
Immutep (IMMP) posted Cash from Financing Activities of -$1603.1 for Q2 2017, down 100.8% on a QoQ basis from $200118.5 in Q2 2016, and down 100.8% year-over-year from $200118.5 in Q2 2016.
Immutep (IMMP) Cash from Financing Activities (2016 - 2017) Analysis & Trends
Immutep's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at -$1603.1 for Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 53,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 68.63 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 238.74 Mn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -1,603.08 |
| Jun 30, 2017 | -1,603.08 |
| Jun 30, 2016 | 200,118.49 |
| Jun 30, 2016 | 200,118.49 |